Effects of Peroxisome Proliferator-Activated Receptor-Gamma Activation With Pioglitazone on Plasma Adipokines in Nondiabetic Patients With Either Hypercholesterolemia or Hypertension
Authors:
- Ana BaracABAna Barac
- Umberto CampiaUCUmberto Campia
- Linda A. MatuskeyLMLinda A. Matuskey
- Li LuLLLi Lu
- Julio A. PanzaJPJulio A. Panza
- 1 April 2008
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 101 (7) , 980-985
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Adiponectin and Cardiovascular DiseaseJACC, 2007
- Peroxisome Proliferator–Activated Receptor-γ Activation With Pioglitazone Improves Endothelium-Dependent Dilation in Nondiabetic Patients With Major Cardiovascular Risk FactorsCirculation, 2006
- Adipocytokines: Emerging therapeutic targetsCurrent Atherosclerosis Reports, 2005
- Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic SyndromeCirculation, 2004
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In HumansThe Journal of Clinical Endocrinology & Metabolism, 2000
- Impaired Endothelium-Dependent Vasodilation in Patients With Essential HypertensionCirculation, 1995
- The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.Circulation, 1993
- Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.Circulation, 1992
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980